Scientist

Fujitsu and Ochanomizu University establish new AI ethics research lab, leveraging AI technologies to promote gender equality

Retrieved on: 
Friday, March 17, 2023
Learning, Gender equality, University, Social, United Nations, Incubator, Policy, Initiative, Lead, Woman, Research, Scientist, Gender, Sustainable Development Goals, Cabinet, Ochanomizu University, Ethics, Ben Goertzel, Risk, Information science, 116th Mechanized Infantry Division (People's Republic of China), AI, Bias, Social collaboration, Sorbonne Paris Cité Alliance, Nursing, Toy, Medical device, Pharmaceutical industry, Renewable energy, Fujitsu

TOKYO, Mar 17, 2023 - (JCN Newswire) - Fujitsu and Ochanomizu University today announced the establishment of the "Fujitsu-Ochanomizu University Social Collaboration Program for AI Ethics", a new joint research laboratory to develop AI solutions contributing to the solution of gender equality issues.

Key Points: 
  • TOKYO, Mar 17, 2023 - (JCN Newswire) - Fujitsu and Ochanomizu University today announced the establishment of the "Fujitsu-Ochanomizu University Social Collaboration Program for AI Ethics", a new joint research laboratory to develop AI solutions contributing to the solution of gender equality issues.
  • Ochanomizu University in April 2022 established the Institute for Gendered Innovations(3) to promote research, innovation, and social communication based on gender perspectives, strengthening its track record in research on gender equality issues.
  • To address these issues, Fujitsu and Ochanomizu University established the "Fujitsu-Ochanomizu University Social Collaboration Program for AI Ethics" to explore the possibility of utilizing AI solutions to contribute to the solution of gender inequalities.
  • To this end, Fujitsu and Ochanomizu University aim to develop practical solutions to gender issues, while addressing the risk of bias in AI by leveraging Fujitsu's strength in R&D in ethical AI technologies and Ochanomizu University's research on gendered innovations.

COLDPLAY - MUSIC OF THE SPHERES: LIVE AT RIVER PLATE CINEMA TICKETS NOW ON SALE AT COLDPLAYCINEMA.LIVE

Retrieved on: 
Wednesday, March 8, 2023
Universe, Astronaut, CJ, Jin, ALSO, Grammy Awards, BAFTA, Yellow, Laser, Carbon, BTS, Music, Sale, Partnership, River Plate, SCREEN, LED, Scientist, DHL, LOS, Trafalgar, Film industry, ScreenX

LOS ANGELES, March 8, 2023 /PRNewswire/ -- Cinema tickets are now on sale for Coldplay - Music Of The Spheres: Live At River Plate at www.coldplaycinema.live. Please click here to view the official trailer.

Key Points: 
  • ALSO SHOWING IN CJ 4DPLEX'S SCREENX, 4DX & 4DX SCREEN PREMIUM FORMATS
    LOS ANGELES, March 8, 2023 /PRNewswire/ -- Cinema tickets are now on sale for Coldplay - Music Of The Spheres: Live At River Plate at www.coldplaycinema.live .
  • It also features guest appearances from multi-Grammy winner H.E.R., and Jin of BTS, who performs alongside Coldplay for the live debut of his record-breaking single The Astronaut.
  • In addition to standard cinema formatting, Coldplay - Music Of The Spheres: Live At River Plate will be released in CJ 4D Plex's premium film formats, including ScreenX, 4DX, and 4DXScreen.
  • The live event is supported by DHL, with whom the band have partnered to reduce carbon emissions from their world tour.

COLDPLAY - MUSIC OF THE SPHERES: LIVE AT RIVER PLATE CINEMA TICKETS NOW ON SALE AT COLDPLAYCINEMA.LIVE

Retrieved on: 
Wednesday, March 8, 2023
Universe, Astronaut, CJ, Jin, ALSO, Grammy Awards, BAFTA, Yellow, Laser, Carbon, BTS, Music, Sale, Partnership, River Plate, SCREEN, LED, Scientist, DHL, LOS, Trafalgar, Film industry, ScreenX

LOS ANGELES, March 8, 2023 /PRNewswire/ -- Cinema tickets are now on sale for Coldplay - Music Of The Spheres: Live At River Plate at www.coldplaycinema.live. Please click here to view the official trailer.

Key Points: 
  • ALSO SHOWING IN CJ 4DPLEX'S SCREENX, 4DX & 4DX SCREEN PREMIUM FORMATS
    LOS ANGELES, March 8, 2023 /PRNewswire/ -- Cinema tickets are now on sale for Coldplay - Music Of The Spheres: Live At River Plate at www.coldplaycinema.live .
  • It also features guest appearances from multi-Grammy winner H.E.R., and Jin of BTS, who performs alongside Coldplay for the live debut of his record-breaking single The Astronaut.
  • In addition to standard cinema formatting, Coldplay - Music Of The Spheres: Live At River Plate will be released in CJ 4D Plex's premium film formats, including ScreenX, 4DX, and 4DXScreen.
  • The live event is supported by DHL, with whom the band have partnered to reduce carbon emissions from their world tour.

EQS-News: Predictmedix: How Artificial Intelligence is revolutionizing medical diagnostics

Retrieved on: 
Wednesday, February 22, 2023
Fatigue, Artificial intelligence, OTC, CE, Infection, Hospital, Physician, Scientist, ISO, Respiratory rate, Pulse, Entry, Diagnosis, Logic, News, Acquisition, FRA, Algorithm, Patient, Cannabis, Eye, Ecosystem, Diabetes, Research, Temperature, Risk, Mining, MGM, COVID-19 pandemic, Heart rate, Vital signs, CAD, Parkinson's disease, ChatGPT, Habit, Dementia, Advertising, Blood pressure, AI, CSE, Thermoregulation, Thermometer, Security (finance), Medical device, Medical imaging, COVID-19

At the latest since ChatGPT, it should be clear to the last person how quickly and how radically artificial intelligence (AI) is changing our lives and habits.

Key Points: 
  • At the latest since ChatGPT, it should be clear to the last person how quickly and how radically artificial intelligence (AI) is changing our lives and habits.
  • It won't be long before AI revolutionizes medical diagnostics as well.
  • One can imagine how such optical methods will one day be used as standard in hospitals or doctor's offices.
  • Artificial intelligence could, for example, be trained to recognize the earliest signs of dementia or Parkinson's disease, but also for high blood pressure or diabetes.

HAYA Therapeutics Adds World-Leading Cardiologist and Dark Genome Pioneer to Advisory Boards

Retrieved on: 
Thursday, February 16, 2023
Biotechnology, Health, Other Health, Pharmaceutical, Oncology, Other Science, Research, General Health, Hospitals, Genetics, Health Technology, Science, Clinical Trials, Cardiology, DNA, SA, Jordan University of Science and Technology, Cornell University, Scientist, Virus, Assistant, Molecular biology, RNA, SAB, OHSU, Division, Patient, Listeria monocytogenes non-coding RNA, Biochemistry, Oregon Health & Science University, University, Therapy, Amyloidosis, Cardiac fibrosis, Medical school, Hypertrophic cardiomyopathy, Genomics, School, Multimedia, Cardiovascular disease, Cancer, CAB, IND, Vaccine, Pharmaceutical industry, Medicine

HAYA Therapeutics, SA , a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Ahmad Masri, M.D., M.S.

Key Points: 
  • HAYA Therapeutics, SA , a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Ahmad Masri, M.D., M.S.
  • View the full release here: https://www.businesswire.com/news/home/20230216005353/en/
    Dr. Ahmad Masri, a Cardiologist and Physician Scientist at the Oregon Health & Science University’s Knight Cardiovascular Institute, has been named the newest member of HAYA Therapeutic’s Clinical Advisory Board.
  • (Photo: Business Wire)
    “The expansion of our advisors with Ahmad and Cedric, and the creation of our Clinical Advisory Board marks a significant milestone for HAYA,” said Samir Ounzain, Ph.D., Co-founder and CEO of HAYA Therapeutics.
  • “HAYA has pioneered a novel approach of targeting disease drivers within the dark genome, and I’m looking forward to working with their team in identifying and understanding relevant clinically-translatable dark genome targets.”

The Beryl Institute Announces New Board and Council Members

Retrieved on: 
Monday, January 30, 2023
University, Mount Sinai Health System, Health, Associate, Movement, Patient experience, Scientist, Human, Duke University Health System, Consumer, Experience, Beryl, PX, Senior, Nursing, Management, Hospital

NASHVILLE, Tenn., Jan. 30, 2023 /PRNewswire-PRWeb/ -- The Beryl Institute announces fourteen new board members and twenty new council members are joining its existing group of volunteer leaders from around the world, committed to driving efforts to transform the human experience in healthcare.

Key Points: 
  • Fourteen board members and twenty council members join existing volunteer leaders, helping drive efforts to transform the human experience in healthcare
    NASHVILLE, Tenn., Jan. 30, 2023 /PRNewswire-PRWeb/ -- The Beryl Institute announces fourteen new board members and twenty new council members are joining its existing group of volunteer leaders from around the world, committed to driving efforts to transform the human experience in healthcare.
  • The Beryl Institute's boards bring valuable insights to guide the Institute forward as the independent central voice and global community of practice for experience improvement.
  • The boards provide practical advice on strategy, growth opportunities and plans, along with valuable insights into market and industry trends.
  • Lucy Eylerts, Associate Vice President of Human Experience, CareMax, Inc.
    Priscilla Ramseur, Chief Nursing and Patient Care Services, Duke Raleigh Hospital
    Jennifer Ball, Director of PX & Advocacy, University of Md Midtown
    Dana Berry, Director of the Experience of Care, UT Health East Texas
    Tyler Gegen, Senior Director of Patient Experience, Mount Sinai Health System

Scientist.com Awards $50,000 to Collegiate STEM Research Stars

Retrieved on: 
Tuesday, January 17, 2023
NIL, UCLA, Scientist.com (company), University, Student, NCAA, Research, University of California, STEM, Scientist, UCSD, SAN, Athlete, Doctor of Philosophy, Medicine, Engineering, Science

SAN DIEGO, Jan. 17, 2023 /PRNewswire-PRWeb/ -- Scientist.com, the biopharma industry's leading R&D marketplace, today announced that 10 undergraduate STEM (Science, Technology, Engineering and Math) students have been chosen as recipients of the inaugural Scientist.com STEM Research NIL Award. The award enables STEM undergrads conducting research within an academic laboratory to be compensated for their work much like collegiate athletes are now compensated under the NCAA's 2019 NIL rule. The grant winners were selected from over 100 applicants, comprising students from 60 universities. Each of the award recipients are college juniors or seniors who have secured a laboratory research position for 2023.

Key Points: 
  • The award enables STEM undergrads conducting research within an academic laboratory to be compensated for their work much like collegiate athletes are now compensated under the NCAA's 2019 NIL rule.
  • Each of the award recipients are college juniors or seniors who have secured a laboratory research position for 2023.
  • "We wanted to recognize undergrad scientists for their contribution to research grant revenue, which often far surpasses the funding generated by collegiate athletic programs," stated Dan Kagan, PhD, President and COO at Scientist.com.
  • For a full list of recipients of the Scientist STEM Research NIL Award, visit https://www.info.scientist.com/nil-award-winners
    To learn more about the program, visit https://www.info.scientist.com/scholarships

Researchers Showcase Their Publications with The Scientist's Journal Club

Retrieved on: 
Monday, January 16, 2023
Molecular biology, Julian Gough (scientist), Doctor of Philosophy, Scientist, Forensic and Scientific Services, Research, Publishing, Journal club

WILMINGTON, Del., Jan. 16, 2023 /PRNewswire-PRWeb/ -- The Scientist proudly launches Journal Club, a webinar series led by our readers that connects researchers to a diverse audience of life scientists. Through Journal Club, scientists have a chance to showcase their recently-published research to The Scientist's readership.

Key Points: 
  • WILMINGTON, Del., Jan. 16, 2023 /PRNewswire-PRWeb/ -- The Scientist proudly launches Journal Club , a webinar series led by our readers that connects researchers to a diverse audience of life scientists.
  • Through Journal Club, scientists have a chance to showcase their recently-published research to The Scientist's readership.
  • The Scientist's Journal Club presents highly innovative molecular biology research conducted by members of our audience.
  • The final presentation will then appear as part of an upcoming Journal Club webinar series.

Carver Biosciences Announces Appointment of Three Members to its Scientific Advisory Board

Retrieved on: 
Tuesday, January 17, 2023
Biotechnology, Technology, Other Health, Health, General Health, Other Science, Research, Infectious Diseases, Nanotechnology, Genetics, Science, Infection, Severe acute respiratory syndrome coronavirus 2, Transdermal, UCPH Department of Biology, Editorial board, University of Washington Department of Bioengineering, Hepatitis B, NIH, United States Air Force Scientific Advisory Board, CRISPR, Associate, ERC, University, CRS, Internal medicine, Stanford University, Engineer, Degenerative disease, Chair, Pharmaceutics, RNA, Molecular Pharmaceutics, New York Genome Center, Scientist, Ludwig Maximilian University of Munich, Doctor of Philosophy, SNF, MIT, Nervous system, Physiology, BS, Y combinator, Computational linguistics, SAB, MS, PRDS, Drug resistance, JCR, Drug delivery, MIT Department of Brain and Cognitive Sciences, Cognitive science, Medical device, Pharmaceutical industry, Brain, Biology, Carver, List of life sciences, Neuroscience, New York University

Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB).

Key Points: 
  • Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB).
  • Cameron Myhrvold Ph.D., co-founder of Carver will serve as the chairman of the SAB.
  • Additional appointments include Uri Lopatin, M.D., Olivia Merkel, Ph.D., and Neville Sanjana, Ph.D.
    “I am thrilled to have Dr. Lopatin, Dr. Merkel and Dr. Sanjana join our advisory board,” said Dr. Walter Strapps, co-founder and CEO of Carver.
  • Dr. Sanjana holds a PhD in Brain and Cognitive Sciences from MIT, a BS in Symbolic Systems and a BA in English from Stanford University.

FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia

Retrieved on: 
Monday, January 9, 2023
Mental Health, Health, Research, Pharmaceutical, Science, Biotechnology, Government, Mental health, Multiple sclerosis, Royal College of Physicians and Surgeons of Canada, Faculty, Associate, CAMH, Drug development, London Olympics, FSD, Neurodegeneration, University Hospitals Plymouth NHS Trust, Neurology, University, Liaquat National Hospital, University of Oxford, Science, Nicotine, DRS, CSE, Neuroscience, University of Bristol, Liver transplantation, Special interest group, Medicine, Scientist, Interest group, European Association for the Study of the Liver, University of Melbourne Faculty of Science, Royal college, Senior, Bachelor of Medicine, Bachelor of Surgery, British, University of Cambridge, FRA, University College London, National Hospital for Neurology and Neurosurgery, Fine chemical, Medical device, Pharmaceutical industry, Philosophy, Neurosurgery, Pharmacology

“We are excited about the incorporation of FSD Pharma Australia, where we have an excellent opportunity to advance our pipeline,” said Mr. Zeeshan Saeed, President of FSD Pharma.

Key Points: 
  • “We are excited about the incorporation of FSD Pharma Australia, where we have an excellent opportunity to advance our pipeline,” said Mr. Zeeshan Saeed, President of FSD Pharma.
  • “Australia is a hotbed for clinical stage biotech companies, and our drug development programs will be able to take advantage of facilities offered by various government incentives in Australia,” added Mr. Saeed.
  • Chataway, Dhanda and Lê have agreed to join our international panel to contribute to our current and new programs,” said Dr. Lakshmi Kotra, CEO of Lucid Psycheceuticals, a wholly owned subsidiary of FSD Pharma.
  • Dr. Chataway received his Bachelor of Medicine & Surgery from Oxford University, and Doctor of Philosophy from Cambridge University.